Locations
Menlo Park, CA, USA · San Francisco, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
11-50 employees
Stage
Series B
founded in
2017
Deepcell is pioneering new methods in single cell analysis by combining innovations in microfluidics, optics, and AI. The company offers the REM-I platform, which utilizes label-free imaging and deep learning to analyze single cell morphology, providing high-dimensional quantitative readouts. This technology differentiates Deepcell in the market by enabling deep characterization of cells, which is crucial for advancing research in biology and medicine. With a strong foundation from Stanford University, Deepcell is positioned to make significant contributions to biomedical research, particularly in diagnostics and therapeutics, leveraging its advanced AI capabilities and microfluidics technology.
Something looks off?